Dan-Feng Liu , Xin Xin , Ru-Jie Shang , Zi Wei Luo , Bing-Zhi Li , Zhi-Hua Liu
{"title":"酿酒酵母细胞工厂微生物合成对苯二甲酸的研究","authors":"Dan-Feng Liu , Xin Xin , Ru-Jie Shang , Zi Wei Luo , Bing-Zhi Li , Zhi-Hua Liu","doi":"10.1016/j.bej.2025.109766","DOIUrl":null,"url":null,"abstract":"<div><div>Terephthalic acid (TPA) is a key industrial chemical widely used in plastic films, bottle containers, pharmaceutical intermediates, and various other applications. Microbial synthesis of TPA has significant potential for sustainable development. In this study, a <em>Saccharomyces cerevisiae</em> cell factory was successfully designed to synthesize TPA using multiple engineering techniques. A genetically engineered <em>S. cerevisiae</em> strain was first constructed and used as the chassis by knocking out six alcohol dehydrogenases to block the branched metabolic pathways of intermediate metabolites such as <em>p</em>-tolualdehyde and 4-carboxybenzaldehyde. Screening of the integration loci helped to improve the titer of <em>p</em>-toluic acid in <em>S. cerevisiae</em>. Through several rounds of integration and enzyme fusion engineering, the heterogeneous TsaMB enzyme was successfully expressed in <em>S. cerevisiae</em>, enabling TPA biosynthesis via a well-planned two-stage biphasic fermentation strategy. Stepwise fermentation optimization revealed critical factors for increasing the TPA yield, with a 2.6-fold increase in the 4-carboxybenzyl alcohol titer and 33.5 % increase in the TPA titer by multiplying the copy number of <em>tsaC</em> gene. Ultimately, a <em>S. cerevisiae</em> cell factory achieved a TPA titer of 131.5 mg/L, corresponding to a conversion yield of 24.1 mol%. These results demonstrate the viability of microbial cell factory for TPA biosynthesis and provide new opportunities for the sustainable production of TPA.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"220 ","pages":"Article 109766"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Microbial synthesis of terephthalic acid via Saccharomyces cerevisiae cell factories\",\"authors\":\"Dan-Feng Liu , Xin Xin , Ru-Jie Shang , Zi Wei Luo , Bing-Zhi Li , Zhi-Hua Liu\",\"doi\":\"10.1016/j.bej.2025.109766\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Terephthalic acid (TPA) is a key industrial chemical widely used in plastic films, bottle containers, pharmaceutical intermediates, and various other applications. Microbial synthesis of TPA has significant potential for sustainable development. In this study, a <em>Saccharomyces cerevisiae</em> cell factory was successfully designed to synthesize TPA using multiple engineering techniques. A genetically engineered <em>S. cerevisiae</em> strain was first constructed and used as the chassis by knocking out six alcohol dehydrogenases to block the branched metabolic pathways of intermediate metabolites such as <em>p</em>-tolualdehyde and 4-carboxybenzaldehyde. Screening of the integration loci helped to improve the titer of <em>p</em>-toluic acid in <em>S. cerevisiae</em>. Through several rounds of integration and enzyme fusion engineering, the heterogeneous TsaMB enzyme was successfully expressed in <em>S. cerevisiae</em>, enabling TPA biosynthesis via a well-planned two-stage biphasic fermentation strategy. Stepwise fermentation optimization revealed critical factors for increasing the TPA yield, with a 2.6-fold increase in the 4-carboxybenzyl alcohol titer and 33.5 % increase in the TPA titer by multiplying the copy number of <em>tsaC</em> gene. Ultimately, a <em>S. cerevisiae</em> cell factory achieved a TPA titer of 131.5 mg/L, corresponding to a conversion yield of 24.1 mol%. These results demonstrate the viability of microbial cell factory for TPA biosynthesis and provide new opportunities for the sustainable production of TPA.</div></div>\",\"PeriodicalId\":8766,\"journal\":{\"name\":\"Biochemical Engineering Journal\",\"volume\":\"220 \",\"pages\":\"Article 109766\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-04-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical Engineering Journal\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1369703X25001408\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X25001408","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Microbial synthesis of terephthalic acid via Saccharomyces cerevisiae cell factories
Terephthalic acid (TPA) is a key industrial chemical widely used in plastic films, bottle containers, pharmaceutical intermediates, and various other applications. Microbial synthesis of TPA has significant potential for sustainable development. In this study, a Saccharomyces cerevisiae cell factory was successfully designed to synthesize TPA using multiple engineering techniques. A genetically engineered S. cerevisiae strain was first constructed and used as the chassis by knocking out six alcohol dehydrogenases to block the branched metabolic pathways of intermediate metabolites such as p-tolualdehyde and 4-carboxybenzaldehyde. Screening of the integration loci helped to improve the titer of p-toluic acid in S. cerevisiae. Through several rounds of integration and enzyme fusion engineering, the heterogeneous TsaMB enzyme was successfully expressed in S. cerevisiae, enabling TPA biosynthesis via a well-planned two-stage biphasic fermentation strategy. Stepwise fermentation optimization revealed critical factors for increasing the TPA yield, with a 2.6-fold increase in the 4-carboxybenzyl alcohol titer and 33.5 % increase in the TPA titer by multiplying the copy number of tsaC gene. Ultimately, a S. cerevisiae cell factory achieved a TPA titer of 131.5 mg/L, corresponding to a conversion yield of 24.1 mol%. These results demonstrate the viability of microbial cell factory for TPA biosynthesis and provide new opportunities for the sustainable production of TPA.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.